20 July, 2025
researchers-discover-links-between-hepatitis-c-and-mental-health-disorders

A new study led by researchers at Johns Hopkins University has identified a potential link between the hepatitis C virus (HCV) and several mental health disorders, including schizophrenia, bipolar disorder, and major depression. The research, published in the journal Translational Psychiatry, reveals traces of HCV in the brain’s protective lining of individuals diagnosed with these psychiatric conditions.

For years, experts have noted correlations between certain viral infections and mental health disorders. However, this study provides direct evidence of viral presence within human brain tissue. The researchers focused their analysis on the choroid plexus, a network of blood vessels and connective tissue responsible for the production of cerebrospinal fluid. This fluid cushions the brain and regulates the exchange of molecules, making the choroid plexus a likely target for viruses.

To conduct their investigation, the team analyzed postmortem brain samples from patients with schizophrenia, bipolar disorder, and major depression, as well as healthy control subjects. The samples were sourced from the Stanley Medical Research Institute, which maintains a repository of brain tissue for studying mental health disorders.

Using the Twist Comprehensive Viral Research Panel, capable of identifying over 3,000 viral species, the researchers found an array of viral sequences within the choroid plexus, particularly in samples from patients with schizophrenia and bipolar disorder. Notably, HCV stood out as the only viral species significantly associated with these disorders.

In a second phase of the study, the authors expanded their analysis to include data from TriNetX, a vast health records database encompassing 285 million patients. This revealed that 3.5 percent of patients with schizophrenia and 3.9 percent of those with bipolar disorder tested positive for HCV. In contrast, the prevalence of HCV among patients with major depression was 1.8 percent, while only 0.5 percent of the control population had the virus.

Despite the presence of viruses in the choroid plexus, the study found no viral traces in the hippocampus, a brain region crucial for learning and memory. This suggests that while the choroid plexus may allow for viral infiltration, the protective layer of the brain effectively keeps pathogens from entering deeper brain structures. Interestingly, patients exhibiting HCV in the lining showed altered gene expression in the hippocampus, indicating a potential influence from the virus even at the periphery.

The implications of this research are significant. While the findings do not suggest that HCV is the sole cause of schizophrenia or bipolar disorder, they open avenues for novel treatment strategies. Sarven Sabunciyan, a neuroscientist involved in the study, noted that the results may indicate that some individuals experiencing psychiatric symptoms might benefit from antiviral treatments. “This could allow certain patients to address their psychiatric symptoms by targeting an underlying infection,” Sabunciyan stated.

While further research is necessary to clarify the relationship between viral presence and psychiatric disorders, the study underscores the importance of exploring the potential role of infections in mental health. As researchers continue to investigate these connections, there is hope that such findings could lead to effective treatments for those affected by devastating psychiatric conditions.